|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2000-11-27
|
|
pubmed:abstractText |
To compare the effects of concurrent administration of cisplatinum (40 mg/m(2)/weekly) with radiation therapy (C-RT) to those induced by radiation therapy alone (RT) on the immune function of patients with locally advanced cervical cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
48
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
997-1006
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:11072156-Adult,
pubmed-meshheading:11072156-Aged,
pubmed-meshheading:11072156-Antineoplastic Agents,
pubmed-meshheading:11072156-Cisplatin,
pubmed-meshheading:11072156-Combined Modality Therapy,
pubmed-meshheading:11072156-Female,
pubmed-meshheading:11072156-Humans,
pubmed-meshheading:11072156-Immunity, Cellular,
pubmed-meshheading:11072156-Interferon-gamma,
pubmed-meshheading:11072156-Interleukin-2,
pubmed-meshheading:11072156-Killer Cells, Natural,
pubmed-meshheading:11072156-Lymphocyte Activation,
pubmed-meshheading:11072156-Lymphocyte Subsets,
pubmed-meshheading:11072156-Membrane Glycoproteins,
pubmed-meshheading:11072156-Middle Aged,
pubmed-meshheading:11072156-Perforin,
pubmed-meshheading:11072156-Pore Forming Cytotoxic Proteins,
pubmed-meshheading:11072156-Prospective Studies,
pubmed-meshheading:11072156-Receptors, Interleukin-2,
pubmed-meshheading:11072156-Uterine Cervical Neoplasms
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Arkansas for Medical Sciences, Little Rock, AR 72205-7199, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
